首页> 美国卫生研究院文献>Chronic Diseases and Translational Medicine >Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients
【2h】

Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients

机译:移植受者中严重急性呼吸系统综合症冠状病毒2感染的推荐预防和管理策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Since December 2019, increasing attention has been paid to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in Wuhan, China. SARS-CoV-2 primarily invades the respiratory tract and lungs, leading to pneumonia and other systemic disorders. The effect of SARS-CoV-2 in transplant recipients has raised significant concerns, especially because there is a large population of transplant recipients in China. Based on the current epidemic situation, this study reviewed publications on this virus and coronavirus disease 2019 (COVID-19), analyzed common features of respiratory viral pneumonias, and presented the currently reported clinical characteristics of COVID-19 in transplant recipients to improve strategies regarding the diagnosis and treatment of COVID-19 in this special population.
机译:自2019年12月以来,人们越来越关注中国武汉市的严重急性呼吸系统综合症冠状病毒2(SARS-CoV-2)流行病。 SARS-CoV-2主要侵袭呼吸道和肺,导致肺炎和其他系统性疾病。 SARS-CoV-2在移植受体中的作用引起了人们的极大关注,尤其是因为中国的移植受体数量众多。根据当前的流行情况,本研究回顾了有关该病毒和冠状病毒病2019(COVID-19)的出版物,分析了呼吸道病毒性肺炎的常见特征,并介绍了目前报道的移植受体中COVID-19的临床特征,以改善关于特殊人群中COVID-19的诊断和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号